mRNA |
Bortezomib |
GDSC1000 |
pan-cancer |
AAC |
-0.064 |
0.2 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
-0.048 |
0.2 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.2 |
mRNA |
BRD-K51490254 |
CTRPv2 |
pan-cancer |
AAC |
0.047 |
0.2 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.069 |
0.2 |
mRNA |
Cetuximab |
GDSC1000 |
pan-cancer |
AAC |
0.041 |
0.2 |
mRNA |
LY317615 |
GDSC1000 |
pan-cancer |
AAC |
-0.042 |
0.2 |
mRNA |
tamatinib |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
AICAR |
GDSC1000 |
pan-cancer |
AAC |
-0.04 |
0.2 |